Stockwinners Market Radar for September 15, 2019 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:46 EDT Fly Intel: Top five weekend stock stories - Catch up on the weekend's top five stories with this list compiled by The Fly: 1. The United Auto Workers union plans to strike against General Motors (GM) following the two sides not reaching a tentative deal before a Saturday night deadline, CNBC's Michael Wayland reported. The last time the union declared a strike at GM was in 2007, the author noted. Meanwhile, President Donald Trump said via Twitter that, "Here we go again General Motors and the United Auto Workers. Get together and make a deal!" 2. An attack on Saudi oil facilities on Saturday is believed to have disrupted half the country's production capacity, making the U.S. the only real holder of the global supply cushion via its ability to raise own output or to soften sanctions against other major oil producers, according to Reuters. Industry sources have said Saudi Arabia will be able to restore supply within days, the publication added. 3. Amerco (UHAL), owner of U-Haul, is one of the "better-kept secrets" in the stock market as it has virtually no analyst coverage, communicates little with investors, and is run like a private business by controlling Shoen family, Andrew Bary wrote in this week's edition of Barron's. Trading at $380, the shares look appealing after having been stuck in a range of $325-$400 for most of the past four years, the author noted. 4. AT&T (T) subsidiary Warner Bros.' "It: Chapter Two" stayed at top the domestic box office, earning another $40.8M. Overseas, the movie also came in at number one with another $47M from 78 markets for a foreign tally of $169.5M and $323.3M globally. The sequel received a B+ CinemaScore and 67% on Rotten Tomatoes. 5. Tapestry (TPR), Bank of America (BAC) saw positive mentions in this week's edition of Barron's.

15:34 EDT Kodiak Sciences announces emerging durability data from Phase 1 study of KSI-301 - Kodiak Sciences announced emerging durability data in patients with wet age-related macular degeneration treated in its Phase 1b clinical study of its investigational therapy KSI-301. "The emerging durability data presented suggest our objective for KSI-301 to be a leading next-generation anti-VEGF therapy with a long-interval durability profile is achievable," said Jason Ehrlich, Kodiak's Chief Medical Officer and Chief Development Officer. "In the presented cohort of treatment-naive wet AMD patients followed for twelve weeks or longer after the loading phase, all achieved a treatment-free interval of three months or longer, with the majority reaching a four- or five-month interval and continuing to be followed without retreatment to date. While early, these durability and efficacy data, together with the continued promising safety data in over 250 injections and 100 patients, support our wet AMD 'DAZZLE' pivotal study design evaluating every three-, four- and five-month dosing with KSI-301."

15:28 EDT L3Harris Technologies completes sale of Harris Night Vision business - L3Harris Technologies completed the previously announced sale of the Harris Night Vision business to Elbit Systems of America for $350M in cash. Proceeds from the transaction will be used to pre-fund the L3Harris pension. L3Harris divested the business as part of the regulatory process relating to the merger of Harris Corporation and L3 Technologies in June 2019. L3Harris retained the legacy L3 Warrior Mission Solutions business that develops and manufactures fully qualified, advanced night vision and electro-optical systems and components for the U.S military, law enforcement, first responder agencies and allied nations across the globe.